Showing results (101-110 of 145) with videos related to
Sort By:
Pageof 15
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 31, 2012
The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous mannerMhairi Baird, Pei Woon Ang, Ian Clark, et al.The Journal of Pathology|January 18, 2022
Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancerDaisuke Yamamoto, Hiroko Oshima, Dong Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 14, 2019
CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genesHaruna Takeda, Shiho Kataoka, Mizuho Nakayama, et al.Cancer Science|July 16, 2013
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasiaTakeyuki Wada, Takatsugu Ishimoto, Ryo Seishima, et al.Gut|May 30, 2014
MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1Tae-Su Han, Keun Hur, Guorong Xu, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|December 7, 2018
Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutationsJon N Buzzelli, Louise O'Connor, Michelle Scurr, et al.Pathology International|January 30, 2024
Identification of uromodulin deposition in the stroma of perinephric fibromyxoid nephrogenic adenoma by mass spectrometryKaori Yoshimura, Yukinobu Ito, Mina Suzuki, et al.Nature Immunology|July 9, 2021
Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cellsSho Hangai, Takeshi Kawamura, Yoshitaka Kimura, et al.Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.Cancer Science|November 26, 2014
Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesotheliomaQi Li, Wei Wang, Yusuke Machino, et al.Pageof 15